These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

779 related articles for article (PubMed ID: 11578128)

  • 1. Metallothionein expression in canine and feline mammary and melanotic tumours.
    Dincer Z; Jasani B; Haywood S; Mullins JE; Fuentealba IC
    J Comp Pathol; 2001; 125(2-3):130-6. PubMed ID: 11578128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metallothionein expression in benign and malignant canine mammary gland tumours.
    Erginsoy SD; Sozmen M; Caldin M; Furlanello T
    Res Vet Sci; 2006 Aug; 81(1):46-50. PubMed ID: 16289156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of steroid receptor expression in normal, dysplastic, and neoplastic canine and feline mammary tissues.
    Millanta F; Calandrella M; Bari G; Niccolini M; Vannozzi I; Poli A
    Res Vet Sci; 2005 Dec; 79(3):225-32. PubMed ID: 16054892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical staining of metallothionein in canine mammary tumors: better survival with higher expression.
    Cardoso SV; Caliari MV; de Aguiar MC; Cassali GD
    Oncol Rep; 2004 Dec; 12(6):1317-21. PubMed ID: 15547757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PCNA and Ki67 proliferation markers as criteria for prediction of clinical behaviour of melanocytic tumours in cats and dogs.
    Roels S; Tilmant K; Ducatelle R
    J Comp Pathol; 1999 Jul; 121(1):13-24. PubMed ID: 10373290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical detection of progesterone and cellular proliferation in canine mammary tumours.
    Thuróczy J; Reisvaag GJ; Perge E; Tibold A; Szilágyi J; Balogh L
    J Comp Pathol; 2007; 137(2-3):122-9. PubMed ID: 17645888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of TopBP1 in canine mammary neoplasia in relation to histological type, Ki67, ERalpha and p53.
    Morris JS; Nixon C; King OJ; Morgan IM; Philbey AW
    Vet J; 2009 Mar; 179(3):422-9. PubMed ID: 18314357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormonal background of canine and feline mammary tumours.
    Rutteman GR; Misdorp W
    J Reprod Fertil Suppl; 1993; 47():483-7. PubMed ID: 8229967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of Cox-1 and Cox-2 in canine mammary tumours.
    Queiroga FL; Alves A; Pires I; Lopes C
    J Comp Pathol; 2007; 136(2-3):177-85. PubMed ID: 17416236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical expression of caveolin-1 in normal and neoplastic canine mammary tissue.
    Amorim I; Lopes CC; Faustino AM; Pereira PD
    J Comp Pathol; 2010 Jul; 143(1):39-44. PubMed ID: 20153867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical demonstration of metallothionein in benign and malignant canine mammary tumours.
    Fuentealba IC; Mullins JE
    Histol Histopathol; 1999 Jan; 14(1):51-61. PubMed ID: 9987650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Immunohistochemical study of HER-2 expression in feline mammary tumours.
    Rasotto R; Caliari D; Castagnaro M; Zanetti R; Zappulli V
    J Comp Pathol; 2011; 144(2-3):170-9. PubMed ID: 20880546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical evaluation of STAT3-p-tyr705 expression in feline mammary gland tumours and correlation with histologic grade.
    Petterino C; Ratto A; Podestà G; Drigo M; Pellegrino C
    Res Vet Sci; 2007 Apr; 82(2):218-24. PubMed ID: 16934302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Canine mammary gland tumours; a histological continuum from benign to malignant; clinical and histopathological evidence.
    Sorenmo KU; Kristiansen VM; Cofone MA; Shofer FS; Breen AM; Langeland M; Mongil CM; Grondahl AM; Teige J; Goldschmidt MH
    Vet Comp Oncol; 2009 Sep; 7(3):162-72. PubMed ID: 19691645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical expression of E-cadherin and β-catenin in feline mammary tumours.
    Zappulli V; De Cecco S; Trez D; Caliari D; Aresu L; Castagnaro M
    J Comp Pathol; 2012; 147(2-3):161-70. PubMed ID: 22520821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular phenotype of primary mammary tumours and distant metastases in female dogs and cats.
    Beha G; Muscatello LV; Brunetti B; Asproni P; Millanta F; Poli A; Benazzi C; Sarli G
    J Comp Pathol; 2014; 150(2-3):194-7. PubMed ID: 24060151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced PTEN protein expression and its prognostic implications in canine and feline mammary tumors.
    Ressel L; Millanta F; Caleri E; Innocenti VM; Poli A
    Vet Pathol; 2009 Sep; 46(5):860-8. PubMed ID: 19429983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and activity of transglutaminase II in spontaneous tumours of dogs and cats.
    Wakshlag JJ; McNeill CJ; Antonyak MA; Boehm JE; Fuji R; Balkman CE; Zgola M; Cerione RA; Page RL
    J Comp Pathol; 2006; 134(2-3):202-10. PubMed ID: 16615935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of vascular endothelial growth factor and its receptor Flk-1/KDR in promoting tumour angiogenesis in feline and canine mammary carcinomas: a preliminary study of autocrine and paracrine loops.
    Millanta F; Silvestri G; Vaselli C; Citi S; Pisani G; Lorenzi D; Poli A
    Res Vet Sci; 2006 Dec; 81(3):350-7. PubMed ID: 16556453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 expression and apoptosis in melanomas of dogs and cats.
    Roels S; Tilmant K; Ducatelle R
    Res Vet Sci; 2001 Feb; 70(1):19-25. PubMed ID: 11170847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.